-
961
Primary Yolk Sac Tumor of the Liver: A Rare Cause of Bile Duct Obstruction
Published 2024-01-01“…He was then started on a curative-intent chemotherapy regimen of bleomycin, etoposide, and cisplatin. …”
Get full text
Article -
962
Sigmoid Carcinoma in an Inguinal Hernia: A Blessing in Disguise?
Published 2013-01-01“…In most cases the goal of treatment is oncological resection followed by adjuvant chemotherapy in order to optimize the survival. In this case report we present a 93-year-old patient with a sigmoid carcinoma inside an irreducible inguinal hernia, which was diagnosed prior to surgery. …”
Get full text
Article -
963
Pneumothorax during Alectinib Treatment for a Uterine Inflammatory Myofibroblastic Tumor with Lung Metastasis
Published 2023-04-01“…After the failure of doxorubicin-based chemotherapy, revised pathology from a palliative hysterectomy revealed an IMT with ALK gene rearrangement. …”
Get full text
Article -
964
A Case Report of Embryonal Botryoid Rhabdomyosarcoma of the Uterine Cervix in a 26- Year-Old Woman
Published 2020-08-01“…The patient is considered group 1A in Intergroup RMS Working Group V (IRSG) criteria and the treatment plan continued with adjuvant vincristine, actinomycin D, cyclophosphamide chemotherapy. In the case of cervical polyps in the fertile age, the specimen must be carefully and histologically examined to rule out genital rabdomyosarcoma. …”
Get full text
Article -
965
Role of enteroscopy in diagnostics of tumors and preneoplastic diseases of the small intestine
Published 2011-06-01“…The methods of videocapsular and balloon enteroscopy which have appeared in 2001 allow to estimate macroscopic appearance of tumor more clearly, to determine its character and location, to carry out biopsy, to obtain the proof for chemotherapy prescription, to remove tumor endoscopically or determine indications for elective surgery.Conclusion. …”
Get full text
Article -
966
Primary Mucinous Adenocarcinoma of the Urinary Bladder with Signet-Ring Cells: Description of an Uncommon Case and Critical Points in Its Management
Published 2016-01-01“…We present an uncommon case of mucinous adenocarcinoma of the bladder (MAB) with signet-ring cells extensively infiltrating prostate gland and pelvic/retroperitoneal lymph node stations and not responsive to usual systemic chemotherapy regimens. This case highlights the important features of MAB including the pattern of tumor spread, the tendency for initial misdiagnosis, and the importance of immunohistochemical study in order to define its primary origin from the bladder and choose the most appropriate treatment since the beginning.…”
Get full text
Article -
967
Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
Published 2014-01-01“…The new fields reductions proposed for classical Hodgkin lymphoma cannot be applied to early stages Nodular Lymphocyte Predominant Hodgkin lymphomas which are usually treated with radiation therapy without systemic chemotherapy.…”
Get full text
Article -
968
Bacteria--phagocyte dynamics,axiomatic modelling and mass-action kinetics
Published 2011-03-01“…Finally, combining this model with a model of neutrophildynamics in the blood after chemotherapy treatments we obtain new insights regarding the development of infections under neutropenic conditions.…”
Get full text
Article -
969
Primary Synovial Sarcoma of the Scrotum
Published 2023-01-01“…A year later, the patient developed liver, vertebrae, and lung metastasis, which was treated with systemic chemotherapy. Treatment failed to improve the hepatic lesion that was then resected, while the spine and lung lesions were followed by radiotherapy. …”
Get full text
Article -
970
Chylothorax from Bilateral Primary Burkitt’s Lymphoma of the Ovaries: A Case Report
Published 2012-01-01“…Disease was advanced at presentation and complicated with both chylothorax and chylous ascites. Response to chemotherapy though dramatic was short lived. This underscores the need for high index of suspicion amongst clinicians. …”
Get full text
Article -
971
Revolution in cancer treatment methods: Perspective review of factors affecting the final results of nanoparticles used in magnetic fluid hyperthermia
Published 2025-03-01“…Magnetic fluid hyperthermia can be used alone or in combination with other conventional therapeutic methods such as chemotherapy, radiotherapy, etc. In order to accurately control the temperature of cancerous tissue and prevent cell necrosis, it is necessary to identify and optimize the factors affecting the magnetic losses of nanoparticles. …”
Get full text
Article -
972
Hemodynamic Instability Induced by Superselective Angiography of the Ophthalmic Artery
Published 2013-01-01“…Since its recent introduction, superselective ophthalmic artery injection of chemotherapy with melphalan has significantly reduced the need for enucleation in patients with advanced disease and also shown to have minimal adverse effects on visual acuity as compared to the conventional therapy. …”
Get full text
Article -
973
Neoadjuvant Immunotherapy and De-escalation of Surgery in Locally Advanced Breast Implant-associated Anaplastic Large Cell Lymphoma
Published 2025-01-01“…The first case was a 52-year-old patient with a left breast mass-like stage III disease who underwent combined targeted immunotherapy and chemotherapy (brentuximab vedotin [BV]–cyclophosphamide, doxorubicin, prednisone [CHP]). …”
Get full text
Article -
974
Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis
Published 2024-01-01“…In the nonradiotherapy group, the DCR and mPFS were higher in the chemotherapy plus immunotherapy subgroup than in the chemotherapy subgroup, with increased toxicity at any grade (DCR: 93.67% vs. 67.86%, p < 0.001; mPFS: 13.53 vs. 5.07 months, p < 0.001; and 68.35% vs. 41.67%, p = 0.001). …”
Get full text
Article -
975
Nomogram model and risk score predicting overall survival and guiding clinical decision in patients with Hodgkin’s lymphoma: an observational study using SEER population-based data...
Published 2022-06-01“…We discovered that Derived American Joint Committee on Cancer (AJCC) Stage Group, lymphoma subtype, radiotherapy and chemotherapy were four independent risk factors affecting the prognosis of HL patients. …”
Get full text
Article -
976
An Unusually Short Latent Period of Therapy-Related Myeloid Neoplasm Harboring a Rare MLL-EP300 Rearrangement: Case Report and Literature Review
Published 2019-01-01“…Therapy-related myeloid neoplasm (t-MN) is a late and lethal complication induced by chemotherapy and/or radiation therapy. Hematological malignancy is one of the most common primary diseases in patients with t-MN. …”
Get full text
Article -
977
Anti-NMDAR-Positive Small-Cell Lung Cancer Paraneoplastic Limbic Encephalitis: A Case Report and Literature Review
Published 2020-01-01“…The patient’s neurological symptoms showed improvement following chemotherapy. Conclusion. This case highlights the importance of recognizing short-term memory loss as a feature of PLE.…”
Get full text
Article -
978
Sequential Docetaxel in ≥7 Cycles Followed by Cabazitaxel Improves Oncological Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer
Published 2021-01-01“…However, it is unclear whether switching to second-line chemotherapy or optimal sequencing of cabazitaxel (CBZ) ensures better clinical outcomes. …”
Get full text
Article -
979
Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer
Published 2025-01-01“…Despite the addition of chemotherapy to radiotherapy to enhance its tumoricidal effects, almost a third of HNC patients suffer from locoregional relapses. …”
Get full text
Article -
980
Management and outcomes of thoracic sarcomas - a collaboration between Orthopaedic Oncology and cardiothoracic surgery: seven-year clinical data from a tertiary referral centre
Published 2025-01-01“…Standard practice currently comprises wide surgical excision, often accompanied by adjuvant chemotherapy and/or radiotherapy. This approach necessitates a multidisciplinary team, ideally in specialised cancer centres. …”
Get full text
Article